Eledon Pharmaceuticals (ELDN) Accumulated Depreciation & Amortization (2013 - 2016)
Eledon Pharmaceuticals (ELDN) reported Accumulated Depreciation & Amortization of $197000.0 for Q4 2016, up 19.39% on a YoY basis from $165000.0 in Q1 2016, and up 19.39% quarter-over-quarter from $165000.0 in Q4 2015.
Eledon Pharmaceuticals (ELDN) Accumulated Depreciation & Amortization (2013 - 2016) Analysis & Trends
Eledon Pharmaceuticals has reported Accumulated Depreciation & Amortization for 4 years, with the latest figure at $197000.0 in Q4 2016.
- For the quarter ending Q4 2016, Accumulated Depreciation & Amortization rose 19.39% year-over-year to $197000.0; the trailing twelve-month figure through Dec 2016 stood at $197000.0 (up 19.39% YoY), and the FY2016 full-year result was $197000.0, up 19.39% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2016 stood at $197000.0, up from $165000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $197000.0 in Q4 2016, with the low at $43000.0 in Q4 2013.
- Historically, Accumulated Depreciation & Amortization has averaged $115750.0 across 4 years, with a median of $111500.0 in 2014.
- Annual changes were most pronounced in 2015 — Accumulated Depreciation & Amortization soared 184.48% — and 2016, when it advanced 19.39%.
- Eledon Pharmaceuticals' Accumulated Depreciation & Amortization stood at $43000.0 in 2013, then soared by 34.88% to $58000.0 in 2014, then jumped by 184.48% to $165000.0 in 2015, then increased by 19.39% to $197000.0 in 2016.
- The last three Accumulated Depreciation & Amortization figures came in at $197000.0 (Q4 2016), $165000.0 (Q4 2015), and $58000.0 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Eledon Pharmaceuticals | 401.35 Mn | 185.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 197,000.00 |
| Dec 31, 2016 | 197,000.00 |
| Dec 31, 2015 | 165,000.00 |
| Dec 31, 2015 | 165,000.00 |
| Dec 31, 2014 | 58,000.00 |
| Dec 31, 2014 | 58,000.00 |
| Dec 31, 2013 | 43,000.00 |
| Dec 31, 2013 | 43,000.00 |